Citigroup’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Citigroup’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-435	Closed	-$1K	–	7989
2015 Q1	$1K	Buy	+435	New	+$1.02K	﹤0.01%	7132
2014 Q4	–	Sell	-1,277	Closed	-$1K	–	7512
2014 Q3	$1K	Buy	1,277 +731	+134%	+$1.32K	﹤0.01%	6999
2014 Q2	$1K	Buy	+546	New	+$1.36K	﹤0.01%	7040
2014 Q1	–	Sell	-84	Closed	–	–	7364
2013 Q4	$0	Buy	+84	New	+$234	﹤0.01%	7282

Other funds holding ECTE

Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Citigroup's ECTE Position: Q2 2015 in Review

Citigroup sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q2 2015, closing a stake of 435 shares — an estimated $1K sold.

Citigroup first reported a position in ECTE in Q4 2013 and held it in 4 quarters. The position peaked at $1K in Q1 2015. 19 funds tracked by Wall St. Rank hold ECTE as of Q2 2015.

Citigroup reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q2 2015 after selling out during the quarter.
Citigroup sold 435 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q2 2015, an estimated $1K.
Citigroup first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q4 2013 and held it in 4 quarters.
Citigroup's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $1K in Q1 2015.
19 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q2 2015.

Based on Citigroup's 13F filing for Q2 2015, filed 13 Aug 2015.